key: cord-1005102-0u6idk0m authors: Rolle, Italia V.; Pearson, Michele L.; Nsubuga, Peter title: Fifty-Five Years of International Epidemic-Assistance Investigations Conducted by CDC’s Disease Detectives date: 2011-12-01 journal: Am J Epidemiol DOI: 10.1093/aje/kwr312 sha: 02c6043efa52586c346bfcfda5549fb5bd3e3725 doc_id: 1005102 cord_uid: 0u6idk0m For more than 60 years, the Centers for Disease Control and Prevention (CDC) has used its scientific expertise to help people throughout the world live healthier, safer, longer lives through science-based health action. In 1951, CDC officially established the Epidemic Intelligence Service to help build public health capacity. During 1950–2005, CDC’s Epidemic Intelligence Service officers conducted 462 international epidemiologic field investigations in 131 foreign countries and 7 territories. Investigations have included responding to emerging infectious and noninfectious disease outbreaks, assisting in disaster response, and evaluating core components of public health programs worldwide. Approximately 81% of investigations were responses to infectious disease outbreaks, but the proportion of investigations related to chronic and other noninfectious conditions increased 7-fold (6%–45%). These investigations have contributed to detecting and characterizing new pathogens (e.g., severe acute respiratory syndrome–associated coronavirus) and conditions, provided insights regarding factors that cause or contribute to disease acquisition (e.g., Ebola hemorrhagic fever), led to development of new diagnostics and surveillance technologies, and provided information upon which global health policies and regulations can be based. CDC’s disease detectives will undoubtedly continue to play a critical role in global health and in responding to emerging global disease threats. Global health has been defined as placing priority on improving health and achieving health equity for all persons worldwide without regard for the concerns and perspectives of individual nations (1, 2) . Societal and environmental trends have highlighted the importance of a borderless, collaborative approach to addressing disease threats. For example, globalization of travel, trade, and communications has resulted in enhanced global connectivity and facilitated global dissemination of infectious and other disease threats (3) (4) (5) (6) . A review of emerging infectious disease events during 1940-2004 revealed hot spots in tropical Africa, Latin America, and Asia (7) . Climate change can result in injuries or illness attributable to floods and heat exposure, increase respiratory problems or vectorborne illnesses, and threaten the safety and availability of food and water supplies (8) . Historically, infectious diseases have dominated the global public health landscape, but noncommunicable diseases (e.g., heart disease, diabetes, and cancer) are increasing in alarming numbers in developing countries as a result of changing dietary habits, decreased physical activity, and increased life expectancy (9, 10) . For more than 60 years, the Centers for Disease Control and Prevention (CDC), an agency of the US Department of Health and Human Services, has used its scientific expertise to help people throughout the world live healthier, safer, longer lives through science-based health action. CDC contributes to global health efforts through activities that include 1) developing surveillance and strategic information systems, 2) strengthening laboratory systems and networks, 3) building the capacity of the public health workforce, 4) participating in public health emergency responses, 5) translating research into public health policy, and 6) monitoring and evaluating public health programs (11) . In 1951, CDC officially established the Epidemic Intelligence Service (EIS) Program as a means of building public health capacity in the United States and abroad (12) (13) (14) (15) (16) . The 2-year training program in applied epidemiology and public health provides EIS officers (EISOs) with opportunities to conduct epidemic-assistance investigations (Epi-Aids) and provide epidemiologic assistance domestically as well as internationally. CDC's EISOs, sometimes called ''disease detectives'', are selected from a variety of disciplines and include physicians, nurses, doctoral-level scientists, and veterinarians from the United States and other countries. Since the inception of the EIS Program, requests from foreign countries for onsite epidemiologic assistance have increased steadily. When CDC receives a request for epidemiologic assistance from a foreign government, the response is usually provided by subject-matter experts related to the public health problem. The majority of requests for assistance are related to an acute disease outbreak and thus are handled through CDC's Epi-Aid system (13) . EISOs and other CDC staff who are deployed in response to the request work closely with public health officials from the host country's ministry of health to identify the cause of the outbreak/public health problem, implement control measures, and provide recommendations to prevent future outbreaks or public health problems (13) . EISOs have assisted nations worldwide in responding to novel, emerging, and established infectious and noninfectious disease threats (17) (18) (19) (20) (21) . In this paper, we summarize and describe the evolution of international epidemiologic field investigations conducted by EISOs during 1946-2005 and highlight selected investigations that illustrate the contribution of these investigations to global health efforts, including disease prevention and control, public health science, and health policy. To identify CDC's international Epi-Aids, we reviewed an electronic database of all field investigations and available published and unpublished reports conducted by CDC during the 1946-2005 period. For this review, an international Epi-Aid was defined as one that occurred in countries or territories other than the United States and Puerto Rico. An Epi-Aid that occurred in multiple countries or locations but was linked to a single etiology was counted as a single investigation and was attributed to the location where the problem was first identified. We excluded investigations linked to travelers returning ill to the United States from a foreign country or cruise ships because the investigation began in the United States and not the foreign country. To characterize the Epi-Aids, we extracted information on the location (i.e., country and World Health Organization (WHO) region), year, number of cases and outbreak-related deaths, type (i.e., infectious, noninfectious, or other), and, when available, the specific etiology (e.g., pathogen or toxin). Epi-Aids during which the investigators were unable to attribute the outbreak or condition to an identifiable cause were classified as being of unknown etiology. To highlight the number of outbreaks that might have been prevented or that might be amenable to recognized public health interventions, we also grouped investigations into the following categories: cancer (e.g., cervical dysplasia or leukemia); noncancerous chronic conditions (e.g., multiple sclerosis); disaster (e.g., wars or floods); foodborne/enteric (e.g., botulism or cholera); injury (e.g., violence); nosocomial (e.g., aspergillosis or Clostridium difficile); nutrition (e.g., anemia or goiter); other infectious (e.g., Brazilian purpuric fever or hepatitis C); parasitic (e.g., malaria or balantidiasis); refugee (e.g., health assessments); reproductive health (e.g., maternal mortality or pregnancy); respiratory (e.g., legionellosis or tuberculosis); sexually transmitted infections (e.g., human immunodeficiency virus or syphilis); surveillance (e.g., nonspecific regarding disease); toxin/poisoning (e.g., aflatoxicosis or cadmium poisoning); vaccine-preventable diseases (e.g., diphtheria, hepatitis B), vectorborne diseases (e.g., dengue fever or yellow fever); zoonotic diseases (e.g., anthrax or Ebola virus); and other/unknown. If available from published reports, we also extracted information regarding factors implicated as causing or contributing to the outbreak, the corrective actions taken, and their public health impact. Note that not all Epi-Aids reports have been published in the scientific literature. Data extracted from reports were entered into an Excel spreadsheet (Microsoft Corporation, Redmond, Washington), imported into STATA version 9 (StataCorp LP, College Station, Texas), and analyzed to provide summary descriptive statistics. A total of 462 international Epi-Aids, representing 131 countries and 7 territories, were identified for the 1946-2005 period; the first occurred in 1950. Readers should note that an EISO did not participate in this investigation because the EIS Program officially began in 1951; it is included as CDC's first international investigation. During a 55-year period beginning with the first international Epi-Aid in 1950, CDC conducted a median of 9 (range: 1-23) international Epi-Aids annually. The distribution of international Epi-Aids by WHO region is displayed in Figure 1 . The Americas accounted for 213 (46%) investigations; the western Pacific region, 78 (17%); the African region, 77 (17%); the European region, 49 (11%); the Southeast Asia region, 26 (6%); and the eastern Mediterranean region, 19 (4%). The African, Americas, and western Pacific regions demonstrate an increasing trend in Epi-Aids, whereas the European and Southeast Asia regions do not reflect consistent increasing trends in the number of Epi-Aids during 1946-2005 ( Figure 2 ). Of the 462 field investigations conducted, 376 (81%) were infectious disease related, 79 (17%) were noninfectious disease related, and 7 (2%) were of unclear etiology. Although infectious diseases accounted for the majority of Epi-Aids during all decades, the proportion of investigations conducted in response to noninfectious causes increased 7-fold (6%-45%) from 1966-1975 to 1995-2005 ( Figure 3) . Overall, foodborne/enteric infections was the most common category of infection, accounting for 27.1% (n ¼ 125 Epi-Aids) of all investigations and representing the largest specific category of investigations in each decade. Vaccine-preventable diseases were the next most frequent, accounting for 21.0% (n ¼ 97) of all investigations. Vectorborne and zoonotic infections accounted for 6.9% and 6.5% of investigations, respectively; respiratory infections, 6.5%; parasitic infections, 5%; nosocomial infections, 2.4%; sexually transmitted infections, 1.1%; and other infectious diseases, 5.2%. Among the investigations of noninfectious diseases and conditions, disaster response (5.4%) and outbreaks caused by toxins/poisonings (4.8%) were the most common (Table 1) . Selected investigations obtained from a literature review highlight CDC's global health contributions by EISOs. Key findings are discussed in the following sections and are summarized in Tables 2-5 by year, location, category, etiology, number of cases (deaths, case-fatality, and attack rates), risk factors, public health actions, and collaborators. During the period 1946-1975 (Table 2 ), 4 investigations are highlighted. An outbreak of poliomyelitis in Barbados in 1963 illustrated the importance of implementing vaccination campaigns to interrupt the outbreak. This outbreak did not end until a second mass immunization campaign was conducted (22) . The first international investigation of a noninfectious disease occurred in New Zealand in 1967. An EISO investigated a cancer cluster; however, the results were inconclusive (CDC, unpublished data, 1966) . In 1971, an outbreak of rubella in Bermuda investigated by EISOs ended 19 days after a vaccination campaign was implemented (23) . Before 1971, the island had not conducted any mass campaigns for rubella vaccine (23) . Investigation of the Lassa fever outbreak in Sierra Leone was notable because fewer deaths occurred than in previous outbreaks in Nigeria and Liberia; a proportion of the population apparently had evidence of prior infection with Lassa fever virus (24) . During this investigation, both nosocomial transmission and person-to-person transmission occurred among families. The investigators recommended use of protective guards in the hospital and quarantining persons with fever to prevent transmission of the disease. Eleven international Epi-Aids are highlighted during 1976-1985 (Table 3) . A drought in Haiti further exacerbated living conditions in communities of low socioeconomic status and having limited safe-water supplies during predrought conditions (25) . A survey conducted for the investigation revealed that illness during the drought was related to having a low income and being unemployed, having a large family size, and being in a household with fewer than one 5-gallon (18.9-L) can of water (25) . The findings from this investigation in Health Organization regions, as follows: AFRO, Regional Office for Africa; EMRO, Office for the Eastern Mediterranean; EURO, Regional Office for Europe; PAHO, Pan American Health Organization (also known as the Regional Office for the Americas); SEARO, Regional Office for the South-East Asia; WPRO, Regional Office for the Western Pacific. Haiti confirmed the importance of using data to inform government planners. The 1977 Ebola investigation was the second documented investigation of a disease that had not been observed before in the communities in which the outbreak began or in other countries around the world (26) . The ensuing outbreak in the Democratic Republic of Congo was closely linked to a hospital where the first group of patients had received injections. Secondary transmission of Ebola virus also occurred among families and within the community. As a result of a thorough investigation that included surveillance, epidemiology, laboratory analysis, contact tracing, and ecologic testing, Ebola was declared a new virus with characteristics comparable to other hemorrhagic fevers (e.g., Lassa fever). Recommendations from the international commission of public health specialists included national campaigns to inform health personnel of correct methods for sterilizing needles and syringes to prevent disease spread, developing and maintaining a list of experienced local staff who can react quickly to another epidemic, and having a ready supply of medicine and personal protective equipment. A third outbreak of Ebola occurred again in South Sudan in 1979 (27) . The investigators determined that patients in a hospital had infected their family members with the disease. Recommendations to prevent Ebola again included quarantine practices and increased surveillance for hemorrhagic feverlike illness. In 3 of the investigations during the 1970s (Lassa fever and Ebola), avoidable deaths occurred among health care staff who had not worn personal protective equipment and who had practiced unsafe standards (e.g., reuse of syringes). In Venezuela, a rural population of Yucpa Indians was affected by an outbreak of hepatitis for 3 years (28) . The investigation concluded that it was the delta virus infection that needed hepatitis B to survive as the etiologic agent in this epidemic. An injury-related investigation in Canada sought to determine the cause of pediatric deaths among children with severe congenital heart disease (29) . A nurse was implicated in the deaths, but the cause of the epidemic was inconclusive. This investigation demonstrated the link between forensic science and epidemiology. The return of an American tourist to the United States from Cancun, Mexico, with cholera resulted in an Epi-Aid examining whether cholera was a problem in the community where the tourist had stayed during vacation (30) . Testing revealed non-01 Vibrio cholerae isolated from 22 samples of 134 stool and rectal swabs, 92% of sewage samples (58/63), 86% of untreated well-water samples (12/14), 1 home storage tank, and 21% of Figure 2 . Number of international epidemic-assistance investigations conducted by the Centers for Disease Control and Prevention's Epidemic Intelligence Service officers, by decade and World Health Organization region-1950-2005. AFRO, Regional Office for Africa; EMRO, Office for the Eastern Mediterranean; EURO, Regional Office for Europe; PAHO, Pan American Health Organization (also known as the Regional Office for the Americas); SEARO, Regional Office for the South-East Asia; WPRO, Regional Office for the Western Pacific. raw seafood samples (5/24). The investigation determined that non-01 V. cholerae was an important cause of diarrhea among Mexican children, and additional studies were needed to determine modes of transmission and reservoirs. An interesting, but also sad investigation was of a Peace Corps volunteer in Kenya who died of rabies (31) . The Peace Corps worker had received preexposure rabies prophylaxis with the standard 3-dose intradermal series of human diploid cell rabies vaccine, but she still experienced rabies within 8 months of receiving the vaccine. Investigators noted the Peace Corps worker had been tested for antibody rabies titer, and her test indicated no signs of a response to the vaccine. As a result of her death, a serosurvey was conducted of other Peace Corps volunteers who had received the rabies vaccine in the United States and other developing countries. Those vaccinated in developing countries had lower levels of rabies antibodies. No reasons could be identified, and emphasis was placed on persons in developing countries being tested after receiving the rabies vaccine. A short report in 1985 alerted physicians to botulism poisoning in British Columbia and requested physicians to report suspect cases (32) . A new disease, Brazilian purpuric fever, was discovered in Sao Paulo, Brazil, in 1985 (33) . The newly recognized illness, purpura fulminans, was determined to be potentially associated with Haemophilus aegyptius. The disease is thought to be rare and is characterized by purpura, fever, and hypotension. In France, as a result of an investigation that implicated nosocomial infection by Aspergillus, the importance of recognizing pseudoepidemics was highlighted (34) . This outbreak was a result of specimens being contaminated in the laboratory. Negative outcomes included unnecessarily treating persons thought to be infected. In Haiti in 1985, an outbreak of diarrheal illness was linked to shigellosis at a hotel (35) . Nine investigations are highlighted for the 1986-1995 period (Table 4 ). An outbreak of hepatitis in a Somalia refugee camp was one of the first to indicate that this disease is a health concern in refugee settings (36) . Parathion contamination of flour in Sierra Leone demonstrated the need to preserve potential sources of contamination (37) . One bakery closed immediately after persons became ill, which led investigators to test the flour and other items and to confirm parathion contamination. One key recommendation based on this investigation is that countries establish laws to regulate the shipment and use of such toxic pesticides as parathion. In Nigeria, data from a survey of 9 villages during an outbreak of yellow fever highlighted the need to undertake mass vaccination campaigns before the next rainy season to prevent future outbreaks (38) . Another pseudoepidemic occurred in Georgetown, Guyana, in 1987 (39) . Local test results indicated a dramatic increase in thallium poisoning cases, but additional testing by CDC demonstrated no evidence of thallium poisoning. Recommendations from this investigation included that the international environmental health community focus on training epidemiologists and that adequate laboratory resources are needed to detect environmental toxicants accurately to identify affected persons but also to rule out false cases. In Senegal, an investigation revealed the necessity of providing the 2-dose regimen of polio vaccine instead of 1 to confer immunity (40) . A measles epidemic in Hungary perhaps was caused in part by vaccine failure (41) . The investigators recommended additional studies. An elevated maternal mortality rate was investigated in 1990 in Mexico (CDC, unpublished data, 1989). However, the investigation revealed that the apparent substantial increase in maternal mortality perhaps was caused by overreporting of deaths and incomplete reporting in certain areas. An investigation in Sierra Leone resulted in a recommendation that, for developing countries, providing Papanicolaou smear screening on a national basis was impractical when a shortage of trained cytotechnologists existed (CDC, unpublished data, 1991). An additional Ebola outbreak occurred in the Democratic Republic of Congo in 1995 (42) . Injections were not identified as a major risk factor for transmission, as was the case in the 1976 outbreak. Instead, transmission was primarily associated with person-to-person contact. Of note, this was the fourth major outbreak of Ebola documented and the first to occur in a large population center. Recommendations arising from this investigation again called for use of personal protective equipment by health care workers, development and implementation of improved surveillance for infectious diseases, better communication between hospitals and public health officials, and quick action to control diseases associated with high case-fatality rates (42) . Fourteen published manuscripts and other unpublished CDC data were reviewed for the period 1996-2005 (Table 5 ). In Haiti, a diethylene glycol-associated outbreak emphasized the need for pharmaceutical producers worldwide to be aware of possible contamination of glycerin and other raw materials containing diethylene glycol and to use quality control measures to identify and prevent potential contamination (43) . A woman's health investigation in Tanzania included determining the incidence and risk factors for infant mortality and low birth weight among Burundi refugees (44) . Adverse pregnancy outcomes were higher among the refugees compared with women in Tanzania, underscoring the need for including quality reproductive health care for women in refugee settings. In 1998, Jamaica's Violence-Related Injury Surveillance System was reviewed by CDC's disease detectives by using CDC's guidelines for evaluating surveillance systems during the pilot testing of the system (45) . Results indicated that the system was simple, flexible, and sensitive, with a positive predictive value of 86%. After the Violence-Related Injury Surveillance System was reviewed, CDC recommended that the system include additional hospitals and that the abstraction form be adapted to include other injury data. After a hurricane in the US Virgin Islands, reported conjunctivitis cases surged (46) . The investigation did not link the outbreak of conjunctivitis with the hurricane but demonstrated that residents should avoid social contact with persons who have 1946-1955 1956-1965 1966-1975 1976-1985 1986-1995 1996-2005 conjunctivitis and that ill persons be restricted from attending school and work; hand washing was also advocated strongly (46) . On the island of Mauritius, with a population of 51,000 persons, a measles epidemic occurred in 2000 (47) . A study confirmed that vaccine efficacy for 1 and 2 measles-mumpsrubella vaccine doses was 92% and 95%, respectively. The study findings indicate that even with highly effective vaccines, widespread outbreaks still can occur because of the high transmissibility of measles virus in crowded communities. An investigation related to severe acute respiratory syndrome (SARS) conducted in 3 countries-Laos, Taiwan, and Thailand-revealed that only 5 (25%) hospitals studied had implemented WHO recommendations for private negativepressure isolation rooms, minimal personal protective equipment for all staff entering the patient's room, and ineffective visitor policies during the early stage of the SARS epidemic (48) . Another SARS-related study conducted in Taiwan also in 2003 evaluated the effectiveness of using a call hotline to identify persons at risk of SARS (49) . Data collection from the hotline was not systematic, which limited how many callers were identified as being at risk of SARS. Of note, the 18 callers at high risk of SARS were not followed up for outcome to determine whether they met the WHO suspected or probable SARS case definition. The hotline was viewed as promising but required detailed documentation of the callers and had a lack of careful follow-up of persons identified at being at risk of SARS. An examination of maternal mortality in Afghanistan determined that direct causes for maternal death included hemorrhage, obstructed labor, pregnancy-induced hypertension, cardiomyopathy, sepsis, obstetric embolism, and early pregnancy outcome (50) . A strategy in response to the investigation developed by the Afghanistan Ministry of Health planned to provide effective antenatal care for all pregnant women by focusing on improved availability of skilled attendants at birth and the coverage, use, and quality of emergency obstetric care, particularly in rural areas. The avian influenza epidemic in a Vietnam investigation indicated that H5N1 viruses were not readily transmitted from person to person (51, 52) . In Bangladesh, a reported epidemic of encephalitis was confirmed, with the assistance of CDC EISOs, to be caused by the Nipah virus (53) . The Epi-Aid investigation included a matched case-control study, environmental assessment, and laboratory testing. The groups that the investigation determined to be at risk were males less than 15 years of age, persons participating in tree climbing, and having contact with persons with Nipah virus. Investigators hypothesized that cases were likely infected from contact with fruit bats or their secretions. This emerging infectious disease was first documented in 1998 and 1999 in Malaysia and Singapore. A famine in Niger documented the coping strategies of families and observed that half of the deaths among children during this time were in part caused by malnutrition (54) . The results of a joint investigation by CDC, the Kenya Field Epidemiology and Laboratory Training Program (FELTP), Kenya's Ministry of Health, and the US Department of Agriculture demonstrated a substantial outbreak associated with aflatoxin-contaminated maize that occurred in eastern International Epi-Aids, 1946-2005 S103 (55). This investigation included not only a descriptive study but also a case-control study and laboratory testing of maize that had been sold in the local market. Recommendations based on findings from the investigation included improving food safety standards in the country to avoid future outbreaks. The contaminated maize was believed to represent a continued exposure to aflatoxin because the homegrown maize implicated in the outbreak had been consumed or discarded. Finally, a rotavirus investigation revealed that if the rotavirus vaccine had been available in Nicaragua, severe rotavirus cases and deaths could have been avoided during the epidemic (56) . In all of the highlighted Epi-Aids, CDC worked with its partners (e.g., ministries of health and WHO) to conduct the investigations. In summary, this review of international Epi-Aids provides insight into the impact of CDC and its EISOs in the field of global health. The discipline of global health has been defined as transcending boundaries, reflecting the modern reality of globalization, encouraging collaboration, opposing all health threats, emphasizing homegrown solutions, and seeking equity for all (1) . Effective responses to global health threats will require a trained public health workforce and effective surveillance systems to detect, prevent, and control the emergence and reemergence of infectious diseases and other disease threats. CDC's EISOs are a unique cadre of public health professionals who possess such skills, and CDC's EIS Program and the public health response efforts and activities presented in this review embody the desired attributes of global health (1, 57) . During its first 55 years, CDC EISOs conducted 462 international epidemiologic field investigations in 131 countries and 7 territories; these field investigations addressed a wide range of infectious and noninfectious health conditions, many preventable by public health measures (e.g., vaccines, clean water, vector control, and food security). Through Epi-Aids, EISOs have helped to detect, characterize, and control new and existing disease threats as well as assess the uptake and impact of such effective interventions as vaccinations to eradicate or prevent vaccine-preventable diseases. Throughout the 55-year period, infectious diseases predominated the international Epi-Aids, but the number of responses to noncommunicable and chronic disease conditions increased substantially, consistent with the increasing prevalence of chronic disease conditions globally. Cardiovascular disease now accounts for approximately 30% of deaths in low-and middle-income countries each year and is accompanied by critical economic repercussions. Building public health infrastructure and health systems with the capacity to implement programs to address cardiovascular disease and other chronic disease risk will be required. These programs should consist of evidence-based prevention strategies, including behavior modification and health policy interventions developed for chronic diseases (e.g., heart disease, diabetes, and obesity) and unhealthy behaviors (e.g., smoking) (58) . This review had certain limitations. We did not have detailed information on all investigations because not all Epi-Aids International Epi-Aids, 1946-2005 S105 resulted in published papers. The categories used to classify the etiology of the investigations were mutually exclusive; however, investigations might have fallen into more than one category used. In addition, we might have underestimated the number of international investigations conducted by EISOs because field investigations and requests for technical assistance can be processed through means other than the Epi-Aid mechanism used for acute responses. Although we might not have captured all of the international activities performed by EISOs during the 60-year period, this review clearly demonstrates the depth and breadth of their response efforts globally. Through its field investigations, the EIS Program has served as an example to the global health community by showing how epidemiologic principles can be applied to address epidemic and nonepidemic conditions. Since 1980, approximately 40 countries, with support from CDC, have established Field Epidemiology Training Programs (FETPs) and FELTPs (59); all were modeled on CDC's EIS Program (60, 61) . Figure 1 indicates that FETPs have developed in each region in which Epi-Aids have been conducted. FETPs/FELTPs help to improve global public health capacity by developing a trained cadre of public health professionals in low-and mediumincome countries. Similar to the EIS Program, FETPs and FELTPs provide training in core public health competencies, including epidemiology, biostatistics, public health surveillance, laboratory practice, communication, computer technology, management and leadership, and prevention effectiveness (62) (63) (64) . CDC continues to provide financial support and technical assistance to 18 programs in 34 countries (includes regional programs) with FETPs and FELTPs (59) . Six other countries (Zimbabwe, Jordan, Saudi Arabia, Thailand, Brazil, and Egypt) were once supported by CDC but now have self-sustaining programs managed by the host country (59) . FETPs also exist in developed countries (e.g., Australia, Canada, Germany, and Spain). Certain challenges lie ahead in the effort to promote and ensure global health and health equity, including globalization, climate change, limited human resources, and lack of established and functioning health and public health systems. Multinational, multidisciplinary collaborations between private, public (governmental and nongovernmental) organizations will be required to strengthen health systems effectively, increase adoption of proven interventions, monitor disease threats and trends, and make efficient use of available resources (57) . Developing a public health workforce trained in the core public health competencies is critical to the success of global health efforts (58) . Certain areas of the world are likely to remain hot spots for emerging infectious disease threats (7) (e.g., drug resistance and vectorborne infections). This review of the first 60 years of Epi-Aids demonstrates the impact that an adequately trained public health workforce can have on global health. Additionally, it confirms the adaptability of the EIS Program and the methods it uses to address emerging and changing disease trends and illustrates the rich contributions that CDC EISOs have made to global health. CDC's disease detectives, working in partnership with WHO, ministries of health, and other organizations, will undoubtedly continue to play a critical role in global health and in responding to future global disease threats. International Epi-Aids, 1946-2005 S107 Table continues International Epi-Aids, 1946-2005 S109 Am J Epidemiol. 2011;174(Suppl):S97-S112 Towards a common definition of global health. Consortium of Universities for Global Health Executive Board The World Health Organization and the transition from ''international'' to ''global'' public health Emerging and re-emerging infectious diseases: the third epidemiologic transition Emerging and reemerging infectious diseases: the perpetual challenge Social and environmental risk factors in the emergence of infectious diseases The challenge of emerging and re-emerging infectious diseases Global trends in emerging infectious diseases A human health perspective on climate change: a report outlining the research needs on the human health effects of climate change The global burden of disease Chronic diseases: the silent global epidemic US Department of Health and Human Services, CDC Training and service in public health practice, 1951-90-CDC's Epidemic Intelligence Service Epidemiologic field investigations by the Centers for Disease Control and Epidemic Intelligence Service Evaluation of field training in the Epidemic Intelligence Service: publications and job choices Nonmedical doctoral-level scientists in the Centers for Disease Control and Prevention's Epidemic Intelligence Service, 1964-1997 Epidemic Intelligence Service of the Centers for Disease Control and Prevention: 50 years of training and service in applied epidemiology Avian influenza: current scenario The SARS epidemic in Mainland China: bringing together all epidemiological data Cholera: a new homeland in Africa? Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control Spread and evolution of Plasmodium falciparum drug resistance Rubella in Bermuda. Termination of an epidemic by mass vaccination Lassa fever in the eastern province of Sierra Leone, 1970-1972. I. Epidemiologic studies Acute water shortage and health problems in Haiti Ebola haemorrhagic fever in Zaire Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela Unexplained deaths in a children's hospital. An epidemiologic assessment Non-01 Vibrio cholerae infections in Cancun, Mexico Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries Brazilian purpuric fever: epidemic purpura fulminans associated with antecedent purulent conjunctivitis. Brazilian Purpuric Fever Study Group Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients Shigellosis at a Caribbean resort. Hamburger and North American origin as risk factors Enterically transmitted non-A, non-B hepatitis-East Africa Fatal parathion poisoning in Sierra Leone Epidemic yellow fever in eastern Nigeria Thallium poisoning. an epidemic of false positives-Georgetown Preliminary report: paralytic poliomyelitis-Senegal Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure Fatalities associated with ingestion of diethylene glycolcontaminated glycerin used to manufacture acetaminophen syrup-Haiti An evaluation of poor pregnancy outcomes among Burundian refugees in Tanzania Surveillance of interpersonal violence in Kingston, Jamaica: an evaluation Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy Infection control practices for SARS in Lao People's Democratic Republic, Taiwan, and Thailand: experience from mobile SARS containment teams Body temperature monitoring and SARS fever hotline Where giving birth is a forecast of death: maternal mortality in four districts of Afghanistan World Health Organization/Global Outbreak Alert and Response Network Avian Influenza Investigation Team in Vietnam World Health Organization International Avian Influenza Investigation Team Risk factors for Nipah virus encephalitis in Bangladesh Retrospective determination of whether famine existed in Niger, 2005: two stage cluster survey Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Kenya Aflatoxicosis Investigation Group Outbreak of rotavirus gastroenteritis with high mortality An assessment of interactions between global health initiatives and country health systems. World Health Organization Maximizing Positive Synergies Collaborative Group Public health requirements for rapid progress in global health Map of FE(L)TPs. Atlanta, GA: US Department of Health and Human Services, CDC/COGH Partnerships in international applied epidemiology training and service Laboratory epidemiologist: skilled partner in field epidemiology and disease surveillance in Kenya Training programmes for field epidemiology Replicating success: developing a standard FETP curriculum Improving global public health leadership through training in epidemiology and public health: the experience of TEPHINET. Training Programs in Epidemiology and Public Health Interventions Network Author affiliations: Division of Public Health Systems and Workforce Development, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia (Italia V. Rolle, Peter Nsubuga); and Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia (Michele L. Pearson).The authors thank Dr. Stephen B. Thacker, C. Kay Smith, Meghan Spall, Dr. Suzanne Elbon, Jennifer Scharff, and CDC's Creative Services for their assistance in developing this manuscript.The findings and conclusions in this review are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.Conflict of interest: none declared.